Race, ethnicity and patient-reported outcomes in childhood-onset systemic lupus erythematosus

CARRA Registry investigators

doi:10.55563/clinexprheumatol/tn0x4k

Race, ethnicity and patient-reported outcomes in childhood-onset systemic lupus erythematosus

CARRA Registry investigators

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Objective This study assesses the association of race/ethnicity with the Patient-Reported Outcomes Measurement Information System (PROMIS^®) in childhood-onset systemic lupus erythematosus (cSLE) patients from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. Methods cSLE patients enrolled in the CARRA Registry within two years of cSLE diagnosis who met ACR and/or SLICC classification criteria for lupus were included. Baseline demographics, laboratory, and disease features as well as patient-reported outcomes were obtained. Multivariable linear regression analysis was used to examine the association of race and ethnicity with PROMIS scores at registry enrolment. Results 425 cSLE patients met inclusion criteria: 83.8% were female, 30.6% non-Hispanic White, 29.7% Black, 22.1% Hispanic. The mean age at diagnosis was 13.9 years (SD 2.5). Household income and highest parental education varied by race/ethnic group, as did frequency of rash, leukopenia, and anti-Smith antibodies. The cohort had low-moderate baseline disease activity (SLEDAI mean: 6.0 [SD 6.7]). The overall PROMIS Global Health mean T-score was 38.6 (SD 6.5), more than one standard deviation below the general population mean of 50. There was no association between race/ethnicity and PROMIS scores in multivariable linear regression analysis. Conclusion In this multiethnic paediatric lupus cohort, PROMIS global health was lower when compared with the general paediatric US population. Moreover, PROMIS global health, pain interference, and physical function mobility did not vary across races/ethnicities.

Original language	English (US)
Pages (from-to)	186-194
Number of pages	9
Journal	Clinical and Experimental Rheumatology
Volume	41
Issue number	1
DOIs	https://doi.org/10.55563/clinexprheumatol/tn0x4k
State	Published - Jan 2023

Bibliographical note

Funding Information:
The authors would like to thank Dr Patricia Katz, PhD (University of California San Francisco) for her invaluable suggestions. The authors also acknowledge CARRA and the ongoing Arthritis Foundation financial support of CARRA. This work could not have been accomplished without the aid of the following organisations: The NIH’s National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) & the Arthritis Foundation. We would also like to thank all participants and hospital sites that recruited patients for the CARRA Registry. The authors thank the following CARRA Registry site principal investigators, sub-investigators and research coordinators:

Funding Information:
The authors would like to thank Dr Patricia Katz, PhD (University of Cali fornia San Francisco) for her invalu able suggestions. The authors also ac knowledge CARRA and the ongoing Arthritis Foundation financial support of CARRA. This work could not have been accom plished without the aid of the follow ing organisations: The NIH’s National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) & the Arthritis Foundation. We would also like to thank all participants and hospital sites that recruited patients for the CARRA Registry. The authors thank the following CARRA Registry site principal investigators, sub-investigators and research coordinators:

Publisher Copyright:
© Copyright CliniCal and ExpErimEntal rhEumatology 2023.

Keywords

health disparities
paediatric lupus
patient-reported outcomes

PubMed: MeSH publication types

Journal Article

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.55563/clinexprheumatol/tn0x4k

Find It

Find It at U of M Libraries

Cite this

@article{e7aa7bf8852c4fa799dfd730db0aaa0d,

title = "Race, ethnicity and patient-reported outcomes in childhood-onset systemic lupus erythematosus",

abstract = "Objective This study assesses the association of race/ethnicity with the Patient-Reported Outcomes Measurement Information System (PROMIS{\textregistered}) in childhood-onset systemic lupus erythematosus (cSLE) patients from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. Methods cSLE patients enrolled in the CARRA Registry within two years of cSLE diagnosis who met ACR and/or SLICC classification criteria for lupus were included. Baseline demographics, laboratory, and disease features as well as patient-reported outcomes were obtained. Multivariable linear regression analysis was used to examine the association of race and ethnicity with PROMIS scores at registry enrolment. Results 425 cSLE patients met inclusion criteria: 83.8% were female, 30.6% non-Hispanic White, 29.7% Black, 22.1% Hispanic. The mean age at diagnosis was 13.9 years (SD 2.5). Household income and highest parental education varied by race/ethnic group, as did frequency of rash, leukopenia, and anti-Smith antibodies. The cohort had low-moderate baseline disease activity (SLEDAI mean: 6.0 [SD 6.7]). The overall PROMIS Global Health mean T-score was 38.6 (SD 6.5), more than one standard deviation below the general population mean of 50. There was no association between race/ethnicity and PROMIS scores in multivariable linear regression analysis. Conclusion In this multiethnic paediatric lupus cohort, PROMIS global health was lower when compared with the general paediatric US population. Moreover, PROMIS global health, pain interference, and physical function mobility did not vary across races/ethnicities.",

keywords = "health disparities, paediatric lupus, patient-reported outcomes",

author = "{CARRA Registry investigators} and Borgia, {R. Ezequiel} and Gurka, {Matthew J.} and Filipp, {Stephanie L.} and Melissa Elder and Michelle Cardel and Shiff, {Natalie J.} and N. Abel and K. Abulaban and A. Adams and M. Adams and R. Agbayani and J. Aiello and S. Akoghlanian and C. Alejandro and E. Allenspach and R. Alperin and M. Alpizar and G. Amarilyo and W. Ambler and E. Anderson and S. Ardoin and S. Armendariz and E. Baker and I. Balboni and S. Balevic and L. Ballenger and S. Ballinger and N. Balmuri and F. Barbar-Smiley and L. Barillas-Arias and M. Basiaga and K. Baszis and M. Becker and H. Bell-Brunson and E. Beltz and H. Benham and S. Benseler and W. Bernal and T. Beukelman and T. Bigley and B. Binstadt and C. Black and M. Blakley and J. Bohnsack and D. Bullock and C. Correll and S. Kramer and A. Tipp and R. Vehe",

note = "Funding Information: The authors would like to thank Dr Patricia Katz, PhD (University of California San Francisco) for her invaluable suggestions. The authors also acknowledge CARRA and the ongoing Arthritis Foundation financial support of CARRA. This work could not have been accomplished without the aid of the following organisations: The NIH{\textquoteright}s National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) & the Arthritis Foundation. We would also like to thank all participants and hospital sites that recruited patients for the CARRA Registry. The authors thank the following CARRA Registry site principal investigators, sub-investigators and research coordinators: Funding Information: The authors would like to thank Dr Patricia Katz, PhD (University of Cali fornia San Francisco) for her invalu able suggestions. The authors also ac knowledge CARRA and the ongoing Arthritis Foundation financial support of CARRA. This work could not have been accom plished without the aid of the follow ing organisations: The NIH{\textquoteright}s National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) & the Arthritis Foundation. We would also like to thank all participants and hospital sites that recruited patients for the CARRA Registry. The authors thank the following CARRA Registry site principal investigators, sub-investigators and research coordinators: Publisher Copyright: {\textcopyright} Copyright CliniCal and ExpErimEntal rhEumatology 2023.",

year = "2023",

month = jan,

doi = "10.55563/clinexprheumatol/tn0x4k",

language = "English (US)",

volume = "41",

pages = "186--194",

journal = "Clinical and Experimental Rheumatology",

issn = "0392-856X",

publisher = "Clinical and Experimental Rheumatology S.A.S.",

number = "1",

}

TY - JOUR

T1 - Race, ethnicity and patient-reported outcomes in childhood-onset systemic lupus erythematosus

AU - CARRA Registry investigators

AU - Borgia, R. Ezequiel

AU - Gurka, Matthew J.

AU - Filipp, Stephanie L.

AU - Elder, Melissa

AU - Cardel, Michelle

AU - Shiff, Natalie J.

AU - Abel, N.

AU - Abulaban, K.

AU - Adams, A.

AU - Adams, M.

AU - Agbayani, R.

AU - Aiello, J.

AU - Akoghlanian, S.

AU - Alejandro, C.

AU - Allenspach, E.

AU - Alperin, R.

AU - Alpizar, M.

AU - Amarilyo, G.

AU - Ambler, W.

AU - Anderson, E.

AU - Ardoin, S.

AU - Armendariz, S.

AU - Baker, E.

AU - Balboni, I.

AU - Balevic, S.

AU - Ballenger, L.

AU - Ballinger, S.

AU - Balmuri, N.

AU - Barbar-Smiley, F.

AU - Barillas-Arias, L.

AU - Basiaga, M.

AU - Baszis, K.

AU - Becker, M.

AU - Bell-Brunson, H.

AU - Beltz, E.

AU - Benham, H.

AU - Benseler, S.

AU - Bernal, W.

AU - Beukelman, T.

AU - Bigley, T.

AU - Binstadt, B.

AU - Black, C.

AU - Blakley, M.

AU - Bohnsack, J.

AU - Bullock, D.

AU - Correll, C.

AU - Kramer, S.

AU - Tipp, A.

AU - Vehe, R.

N1 - Funding Information: The authors would like to thank Dr Patricia Katz, PhD (University of California San Francisco) for her invaluable suggestions. The authors also acknowledge CARRA and the ongoing Arthritis Foundation financial support of CARRA. This work could not have been accomplished without the aid of the following organisations: The NIH’s National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) & the Arthritis Foundation. We would also like to thank all participants and hospital sites that recruited patients for the CARRA Registry. The authors thank the following CARRA Registry site principal investigators, sub-investigators and research coordinators: Funding Information: The authors would like to thank Dr Patricia Katz, PhD (University of Cali fornia San Francisco) for her invalu able suggestions. The authors also ac knowledge CARRA and the ongoing Arthritis Foundation financial support of CARRA. This work could not have been accom plished without the aid of the follow ing organisations: The NIH’s National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) & the Arthritis Foundation. We would also like to thank all participants and hospital sites that recruited patients for the CARRA Registry. The authors thank the following CARRA Registry site principal investigators, sub-investigators and research coordinators: Publisher Copyright: © Copyright CliniCal and ExpErimEntal rhEumatology 2023.

PY - 2023/1

Y1 - 2023/1

N2 - Objective This study assesses the association of race/ethnicity with the Patient-Reported Outcomes Measurement Information System (PROMIS®) in childhood-onset systemic lupus erythematosus (cSLE) patients from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. Methods cSLE patients enrolled in the CARRA Registry within two years of cSLE diagnosis who met ACR and/or SLICC classification criteria for lupus were included. Baseline demographics, laboratory, and disease features as well as patient-reported outcomes were obtained. Multivariable linear regression analysis was used to examine the association of race and ethnicity with PROMIS scores at registry enrolment. Results 425 cSLE patients met inclusion criteria: 83.8% were female, 30.6% non-Hispanic White, 29.7% Black, 22.1% Hispanic. The mean age at diagnosis was 13.9 years (SD 2.5). Household income and highest parental education varied by race/ethnic group, as did frequency of rash, leukopenia, and anti-Smith antibodies. The cohort had low-moderate baseline disease activity (SLEDAI mean: 6.0 [SD 6.7]). The overall PROMIS Global Health mean T-score was 38.6 (SD 6.5), more than one standard deviation below the general population mean of 50. There was no association between race/ethnicity and PROMIS scores in multivariable linear regression analysis. Conclusion In this multiethnic paediatric lupus cohort, PROMIS global health was lower when compared with the general paediatric US population. Moreover, PROMIS global health, pain interference, and physical function mobility did not vary across races/ethnicities.

AB - Objective This study assesses the association of race/ethnicity with the Patient-Reported Outcomes Measurement Information System (PROMIS®) in childhood-onset systemic lupus erythematosus (cSLE) patients from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. Methods cSLE patients enrolled in the CARRA Registry within two years of cSLE diagnosis who met ACR and/or SLICC classification criteria for lupus were included. Baseline demographics, laboratory, and disease features as well as patient-reported outcomes were obtained. Multivariable linear regression analysis was used to examine the association of race and ethnicity with PROMIS scores at registry enrolment. Results 425 cSLE patients met inclusion criteria: 83.8% were female, 30.6% non-Hispanic White, 29.7% Black, 22.1% Hispanic. The mean age at diagnosis was 13.9 years (SD 2.5). Household income and highest parental education varied by race/ethnic group, as did frequency of rash, leukopenia, and anti-Smith antibodies. The cohort had low-moderate baseline disease activity (SLEDAI mean: 6.0 [SD 6.7]). The overall PROMIS Global Health mean T-score was 38.6 (SD 6.5), more than one standard deviation below the general population mean of 50. There was no association between race/ethnicity and PROMIS scores in multivariable linear regression analysis. Conclusion In this multiethnic paediatric lupus cohort, PROMIS global health was lower when compared with the general paediatric US population. Moreover, PROMIS global health, pain interference, and physical function mobility did not vary across races/ethnicities.

KW - health disparities

KW - paediatric lupus

KW - patient-reported outcomes

UR - http://www.scopus.com/inward/record.url?scp=85147047208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85147047208&partnerID=8YFLogxK

U2 - 10.55563/clinexprheumatol/tn0x4k

DO - 10.55563/clinexprheumatol/tn0x4k

M3 - Article

C2 - 36135940

AN - SCOPUS:85147047208

SN - 0392-856X

VL - 41

SP - 186

EP - 194

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

IS - 1

ER -

Race, ethnicity and patient-reported outcomes in childhood-onset systemic lupus erythematosus

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this